• C K Spies, T Bruckner, L P Müller, F Unglaub, P Eysel, S Löw, and M J Filbert.
• Hand Surgery, Vulpius Klinik, Vulpius Straße 29, 74906, Bad Rappenau, Germany. christianspies27@gmail.com.
• Arch Orthop Trauma Surg. 2021 Oct 1; 141 (10): 1807-1814.

PurposeThe purpose of this study was to report long-term objective and patient-reported outcome after arthroscopic debridement of central degenerative triangular fibrocartilage complex (TFCC) lesions.MethodsA total of 17 patients with central degenerative TFCC (Palmer type 2C) lesions and ulnar positive variance who were treated by arthroscopic debridement were retrospectively reviewed. Mean follow-up was 8.8 years. Assessment facilitating the Modified Mayo Wrist score (MMWS), the Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH score), recording of pain level and of patient satisfaction, and radiological examination were done.ResultsPatients reached a pain level of 1.7 VAS, MMW score of 92, and DASH score of 22. No significant differences could be detected between the operated and the contralateral extremity regarding range of motion and grip strength for all patients. No perioperative complications occurred.ConclusionArthroscopic debridement of central degenerative TFCC lesions is safe, reliable, and efficacious even for ulnar positive variance.Level Of EvidenceTherapeutic IV.© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

15 keywords...

hide…